KBC Group NV Sells Stake in Merck Amid Cancer Therapy Success
KBC Group NV has reduced its holdings in Merck & Co., Inc. (NYSE:MRK) by selling 86,325 shares in the second quarter, according to the company's most recent SEC filing.
The firm now owns 1,131,286 shares of the company's stock after the sale, representing a 7.1% decrease in its holdings.
As of its latest SEC filing, KBC Group NV's holdings in Merck & Co., Inc. were worth approximately $145,370,000.